Linda Borst
Leids Universitair Medisch Centrum
4 papers found
Refreshing results…
NKG2A is a late immune checkpoint on CD8 T cells and marks repeated stimulation and cell division
UploadThe NKG2A - HLA-E axis as a novel checkpoint in the tumor microenvironment
Download from aacrjournals.orgMonalizumab: inhibiting the novel immune checkpoint NKG2A
Download from link.springer.comNKG2A Blockade Potentiates CD8 T Cell Immunity Induced by Cancer Vaccines
UploadMissing publications? Search for publications with a matching author name.